Free Trial

Zacks Research Expects Reduced Earnings for Moelis & Company

Moelis & Company logo with Finance background

Moelis & Company (NYSE:MC - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2025 earnings per share estimates for shares of Moelis & Company in a report issued on Monday, April 14th. Zacks Research analyst R. Department now expects that the asset manager will post earnings of $0.40 per share for the quarter, down from their prior estimate of $0.52. The consensus estimate for Moelis & Company's current full-year earnings is $2.97 per share. Zacks Research also issued estimates for Moelis & Company's Q3 2025 earnings at $0.51 EPS, Q3 2026 earnings at $0.68 EPS, Q4 2026 earnings at $0.63 EPS and Q1 2027 earnings at $0.91 EPS.

Several other brokerages have also recently issued reports on MC. Morgan Stanley reduced their price objective on Moelis & Company from $70.00 to $42.00 and set an "underweight" rating for the company in a research note on Monday, April 7th. JMP Securities reaffirmed a "market perform" rating on shares of Moelis & Company in a report on Thursday, February 6th. The Goldman Sachs Group decreased their target price on shares of Moelis & Company from $86.00 to $75.00 and set a "neutral" rating for the company in a research report on Friday, March 14th. Wells Fargo & Company decreased their price objective on Moelis & Company from $63.00 to $55.00 and set an "equal weight" rating for the company in a report on Tuesday, April 8th. Finally, StockNews.com lowered Moelis & Company from a "buy" rating to a "hold" rating in a report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $62.50.

View Our Latest Stock Analysis on Moelis & Company

Moelis & Company Stock Down 4.1 %

Shares of Moelis & Company stock traded down $2.10 during trading on Wednesday, reaching $49.53. The company's stock had a trading volume of 213,833 shares, compared to its average volume of 727,487. The company has a 50-day simple moving average of $61.50 and a two-hundred day simple moving average of $69.58. Moelis & Company has a 1-year low of $46.24 and a 1-year high of $82.89. The company has a market cap of $3.71 billion, a price-to-earnings ratio of 28.14 and a beta of 1.53.

Moelis & Company (NYSE:MC - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The asset manager reported $1.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.79. Moelis & Company had a net margin of 11.39% and a return on equity of 38.49%.

Moelis & Company Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 27th. Shareholders of record on Tuesday, February 18th were given a $0.65 dividend. The ex-dividend date of this dividend was Tuesday, February 18th. This represents a $2.60 dividend on an annualized basis and a yield of 5.25%. This is a positive change from Moelis & Company's previous quarterly dividend of $0.60. Moelis & Company's dividend payout ratio (DPR) is currently 147.73%.

Insider Transactions at Moelis & Company

In other news, CEO Kenneth Moelis sold 9,712 shares of the business's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $74.00, for a total value of $718,688.00. Following the completion of the sale, the chief executive officer now directly owns 209,235 shares of the company's stock, valued at approximately $15,483,390. The trade was a 4.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kenneth Shropshire sold 2,551 shares of the business's stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $72.30, for a total value of $184,437.30. Following the completion of the sale, the director now owns 6,940 shares of the company's stock, valued at approximately $501,762. This represents a 26.88 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,721 shares of company stock valued at $1,677,017. 6.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Edgestream Partners L.P. acquired a new stake in Moelis & Company during the fourth quarter worth approximately $2,784,000. Charles Schwab Investment Management Inc. boosted its holdings in shares of Moelis & Company by 1.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 935,552 shares of the asset manager's stock worth $69,119,000 after purchasing an additional 12,632 shares during the last quarter. Hodges Capital Management Inc. purchased a new stake in shares of Moelis & Company in the fourth quarter valued at $9,149,000. Raymond James Financial Inc. acquired a new position in Moelis & Company in the fourth quarter valued at $27,855,000. Finally, Entropy Technologies LP purchased a new position in Moelis & Company during the fourth quarter worth about $412,000. 91.53% of the stock is owned by hedge funds and other institutional investors.

About Moelis & Company

(Get Free Report)

Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments.

Further Reading

Earnings History and Estimates for Moelis & Company (NYSE:MC)

Should You Invest $1,000 in Moelis & Company Right Now?

Before you consider Moelis & Company, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.

While Moelis & Company currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?
Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines